Publications by authors named "Muhammad Taha Altaf"

Claim this Profile
F
FDA approves Journavx (Suzetrigine) as the first non-opioid treatment for moderate to severe acute pain.
Muhammad Bilal Aamir, Pinkey Kumari, Muhammad Taha Altaf, Mohammed Quader Naseer, Malik Olatunde Oduoye

Ann Med Surg (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to editor: Nicorandil: a word of caution on growing long-term risks versus benefits.
Rana Muhammad Omar Draz Khan, Muhammad Taha Altaf, Maleeha Ashraf, Hamza Yousuf Ibrahim

Int Urol Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Evolving Trends of Hypertension and Cerebral Infarction-Related Mortality in the United States From 2000 to 2020".
Iftikhar Khan, Maryam Athar, Mohammad Ahmad, Eshal Amir, Anas M Din Bashir, Muhammad Taha Altaf

Am J Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis